Skip To Main Content
Russell R Bakken on Muck Rack

Russell R Bakken

As seen in: Nature, MDPI, The Journal of Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Russell R

Contact Russell R, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses

|
By Connor Weidle, Natalie Brunette, Samuel Wrenn, Brooke M. Fiala, Rashmi Ravichandran, Kenneth D. Carr, Samantha E Zak, Elizabeth E. Zumbrun, Russell R Bakken, Michael Murphy, Sidney Man-Ngai Chan, Rebecca Skotheim, Lauren Carter, Colin E. Correnti, John M. Dye, David Baker, Neil King, Andrew J. Borst, Lance Stewart, Zhitong Peng
| Nature Verified
Abstract Both Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV) are members of the genus Ebolavirus and cause outbreaks marked by high fatality rates and repeated spillover from animal reservoirs. Filoviral glycoproteins (GPs) are the primary targets of neutralizing antibodies and form the basis of current vaccines.
Open in Who Shared Issue with article?

Syrian Hamsters Model Does Not Reflect Human-Like Disease after Aerosol Exposure to Encephalitic Alphaviruses

|
By Christina Gardner, Rebecca Erwin-Cohen, Bridget Lewis, Russell R Bakken
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared View Duplicates (173) Issue with article?

Immune correlates for VEEV replicon vaccine protection against Ebolavirus

|
By Spencer W. Stonier, John Dye, Rebekah M James, Nicole M Josleyn, Russell R Bakken
| The Journal of Immunology Verified
The progress of filovirus vaccines has advanced greatly due in part to the urgent need to develop countermeasures for the unprecedented Ebolavirus (EBOV) outbreak in West Africa. While a variety of vaccination approaches have been moved into clinical trials, the understanding of what constitutes a protective response after vaccination is still under investigation.
Open in Who Shared Issue with article?
See all 3 articles